Antitumor activity of abiraterone, enzalutamide, and docetaxel following treatment with diethystilbestrol in castration-resistant prostate cancer.

被引：0
|
作者：
Assoun, Sandra
Campedel, Luca
Roupret, Morgan
Vaessen, Christophe
Parra, Jerome
Boostandoost, Haide Angele
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.e581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e581
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer.
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eliahu
    Sharid, David
    Hayat, Henry
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    Kovel, Svetlana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
    Cheng, H. H.
    Gulati, R.
    Azad, A.
    Nadal, R.
    Twardowski, P.
    Vaishampayan, U. N.
    Agarwal, N.
    Heath, E. I.
    Pal, S. K.
    Rehman, H-t
    Leiter, A.
    Batten, J. A.
    Montgomery, R. B.
    Galsky, M. D.
    Antonarakis, E. S.
    Chi, K. N.
    Yu, E. Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (02) : 122 - 127
  • [3] Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
    H H Cheng
    R Gulati
    A Azad
    R Nadal
    P Twardowski
    U N Vaishampayan
    N Agarwal
    E I Heath
    S K Pal
    H-t Rehman
    A Leiter
    J A Batten
    R B Montgomery
    M D Galsky
    E S Antonarakis
    K N Chi
    E Y Yu
    Prostate Cancer and Prostatic Diseases, 2015, 18 : 122 - 127
  • [4] Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
    Schrader, Andres Jan
    Boegemann, Martin
    Ohlmann, Carsten-H.
    Schnoeller, Thomas J.
    Krabbe, Laura-Maria
    Hajili, Turkan
    Jentzmik, Florian
    Stoeckle, Michael
    Schrader, Mark
    Herrmann, Edwin
    Cronauer, Marcus V.
    EUROPEAN UROLOGY, 2014, 65 (01) : 30 - 36
  • [5] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Schmid, Sebastian Christoph
    Geith, Alexander
    Boeker, Alena
    Tauber, Robert
    Seitz, Anna Katharina
    Kuczyk, Markus
    von Klot, Christoph
    Gschwend, Juergen Erich
    Merseburger, Axel Stuart
    Retz, Margitta
    ADVANCES IN THERAPY, 2014, 31 (02) : 234 - 241
  • [6] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sebastian Christoph Schmid
    Alexander Geith
    Alena Böker
    Robert Tauber
    Anna Katharina Seitz
    Markus Kuczyk
    Christoph von Klot
    Jürgen Erich Gschwend
    Axel Stuart Merseburger
    Margitta Retz
    Advances in Therapy, 2014, 31 : 234 - 241
  • [7] Clinical Activity of Enzalutamide Versus Docetaxel in Men With Castration-Resistant Prostate Cancer Progressing After Abiraterone
    Suzman, Daniel L.
    Luber, Brandon
    Schweizer, Michael T.
    Nadal, Rosa
    Antonarakis, Emmanuel S.
    PROSTATE, 2014, 74 (13): : 1278 - 1285
  • [8] Treatment of metastatic castration-resistant prostate cancer. Drug interaction potentials of abiraterone acetate and enzalutamide
    Lipp, H-P.
    Miller, K.
    UROLOGE, 2016, 55 (06): : 766 - 771
  • [9] Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eli
    Sharid, David
    Hayat, Henry
    Hanovich, Ekaterina
    Kovel, Svetlana
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] Continuing enzalutamide with docetaxel in castration-resistant prostate cancer
    Shiota, Masaki
    LANCET ONCOLOGY, 2022, 23 (11): : 1345 - 1347
12345